These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 7502802
1. Activation of lamina propria T lymphocytes in Crohn's disease. Qiao L, Schürmann G, Meuer SC, Autschbach F. Adv Exp Med Biol; 1995; 371B():1287-91. PubMed ID: 7502802 [Abstract] [Full Text] [Related]
2. Immunoregulatory function of lamina propria T cells in Crohn's disease. James SP, Fiocchi C, Graeff AS, Strober W. Gastroenterology; 1985 May; 88(5 Pt 1):1143-50. PubMed ID: 2858428 [Abstract] [Full Text] [Related]
3. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M. Gut; 1987 Jun; 28(6):745-53. PubMed ID: 3040543 [Abstract] [Full Text] [Related]
4. T cell receptor repertoire and mitotic responses of lamina propria T lymphocytes in inflammatory bowel disease. Qiao L, Golling M, Autschbach F, Schürmann G, Meuer SC. Clin Exp Immunol; 1994 Aug; 97(2):303-8. PubMed ID: 8050181 [Abstract] [Full Text] [Related]
13. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Boirivant M, Marini M, Di Felice G, Pronio AM, Montesani C, Tersigni R, Strober W. Gastroenterology; 1999 Mar; 116(3):557-65. PubMed ID: 10029614 [Abstract] [Full Text] [Related]
14. Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients. James SP, Fiocchi C, Graeff AS, Strober W. Gastroenterology; 1986 Dec; 91(6):1483-9. PubMed ID: 2945749 [Abstract] [Full Text] [Related]
15. Lymphocyte activation in vivo in the intestinal mucosa of patients with Crohn's disease. Konttinen YT, Bergroth V, Nordström D, Segerberg-Konttinen M, Seppälä K, Salaspuro M. J Clin Lab Immunol; 1987 Feb; 22(2):59-63. PubMed ID: 3298655 [Abstract] [Full Text] [Related]
16. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, Dulphy N, Caillat-Zucman S, Paul P, Gornet JM, Douay C, Ravet S, Tamouza R, Charron D, Lémann M, Mayer L, Toubert A. Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210 [Abstract] [Full Text] [Related]
19. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. Takayama T, Kamada N, Chinen H, Okamoto S, Kitazume MT, Chang J, Matuzaki Y, Suzuki S, Sugita A, Koganei K, Hisamatsu T, Kanai T, Hibi T. Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936 [Abstract] [Full Text] [Related]
20. T cell antigen receptor V gene usage. Increases in V beta 8+ T cells in Crohn's disease. Posnett DN, Schmelkin I, Burton DA, August A, McGrath H, Mayer LF. J Clin Invest; 1990 Jun; 85(6):1770-6. PubMed ID: 1971828 [Abstract] [Full Text] [Related] Page: [Next] [New Search]